TMCnet6h
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Paul Goepfert, MD, Director for the Alabama Vaccine Research Clinic, stated: “I’m excited for the opportunity to follow-up on my previous work regarding the combination of Ampligen and FluMist, ...
AIM announces principal investigator for Ampligen, FluMist clinical study
AIM ImmunoTech (AIM) announced that Paul Goepfert, MD, of the University of Alabama-Birmingham, has agreed to act as the Principal Investigator ...
Hosted on MSN1d
AIM Vaccine s mRNA RSV Vaccine Approved for U S Clinical Trials
Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) ...
Vietnam Investment Review on MSN3d
AIM Vaccine s mRNA Shingles Vaccine Submits Clinical Application to the U S
Another Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative ...
Yahoo Finance4d
AIM Vaccine Integrates DeepSeek: Innovative Technology and Growth Potential Support Valuation Upside
HONG KONG, Feb. 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 23, 2025, announced that the company is fully ...
The New Republic on MSN1dOpinion
Trump Takes Aim at Social Security in Dreadful New Layoffs Order
The sticker-shock warning came amid the unveiling of a new plan by the Trump administration to alleviate egg prices, which ...